"tyrosine kinase" trang 7 - tải miễn phí từ tailieunhanh
The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations

The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations
8    74    0
Clinical and mutational features of Vietnamese children with X-linked agammaglobulinemia

Clinical and mutational features of Vietnamese children with X-linked agammaglobulinemia
5    49    0
Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient

Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient
6    75    0
The effects of combination treatments on drug resistance in chronic myeloid leukaemia: An evaluation of the tyrosine kinase inhibitors axitinib and asciminib

The effects of combination treatments on drug resistance in chronic myeloid leukaemia: An evaluation of the tyrosine kinase inhibitors axitinib and asciminib
14    76    0
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
8    72    0
All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells

All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells
9    80    0
EGFR mutation testing and treatment decisions in patients progressing on firstor second-generation epidermal growth factor receptor tyrosine kinase inhibitors

EGFR mutation testing and treatment decisions in patients progressing on firstor second-generation epidermal growth factor receptor tyrosine kinase inhibitors
13    89    0
Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling

Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling
15    71    0
Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalinfixed paraffin-embedded tissue of nonsmall cell lung cancer

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalinfixed paraffin-embedded tissue of nonsmall cell lung cancer
10    80    0
A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: Treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)

A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: Treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)
6    95    0
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine

A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine
16    102    0
EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
9    82    0
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: Predictors and pitfalls

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: Predictors and pitfalls
8    63    0
EGFR modulates complement activation in head and neck squamous cell carcinoma

EGFR modulates complement activation in head and neck squamous cell carcinoma
12    70    0
The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations
6    94    0
Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: A case report

Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: A case report
6    47    0
Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiationinduced abdominal wall angiosarcoma with low-dose apatinib: A case report

Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiationinduced abdominal wall angiosarcoma with low-dose apatinib: A case report
6    89    0
Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: Implications for treatment and discovery of potential therapeutic signatures

Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: Implications for treatment and discovery of potential therapeutic signatures
12    80    0
Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis

Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
8    97    0
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: A case report
4    63    0